Company Profile

Galen Biotechnologies LLC
Profile last edited on: 3/28/16      CAGE: 54Q43      UEI:

Business Identifier: Drug discovery
Year Founded
2013
First Award
2014
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

136 Sinsheimer Labs
Santa Cruz, CA 95060
   (650) 888-6329
   admin@galenbiotech.com
   www.galenbiotech.com/
Location: Single
Congr. District: 18
County: Santa Cruz

Public Profile

Galen Biotechnologies, LLC discovers and develops potent and selective small molecule drugs by radically reengineering ribosomal translation. The firm's Biologically Inspired-Chemically Designed Molecules combine the strengths of encoded biological library diversity with small molecule pharmacophores for rapid discovery and design of lead candidate therapeutics. This new platform will enable the rapid and systematic exploration of drug candidates against ‘undruggable’ therapeutic targe

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $257,254
Project Title: Genetically Encoded Fragment-Based Drug Discovery
2014 1 NIH $168,413
Project Title: Cell-Free Synthesis of Site-specific Phosphothreonine Proteins

Key People / Management

  Christopher Murray

Company News

There are no news available.